TREATMENT OF THE ANEMIA OF PROGRESSIVE RENAL-FAILURE WITH RECOMBINANT HUMAN ERYTHROPOIETIN

[1] KIDNEY AND ERYTHROPOIESIS [J]. AMERICAN JOURNAL OF MEDICINE, 1968, 44 (05) : 725 - +

[2] BALDWIN DS, 1986, CONTEMP ISS NEPHROL, V14, P81

[3] BOMMER J, 1987, Nephrology Dialysis Transplantation, V2, P238

[4] RENAL FUNCTION DURING CHRONIC ANEMIA IN MAN [J]. BLOOD, 1947, 2 (02) : 192 - 202

[5] BROD J, 1967, ISRAEL J MED SCI, V3, P53

[6] BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS [J]. BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6605): : 1017 - 1020

[7] CAZZOLA M, 1987, BLOOD, V69, P296

[8] CHAPLIN H, 1953, CLIN SCI, V12, P359

[9] HEMATOPOIETIC INHIBITORS IN CHRONIC-RENAL-FAILURE - LACK OF INVITRO SPECIFICITY [J]. KIDNEY INTERNATIONAL, 1986, 29 (03) : 641 - 648

[10] ESCHBACH JW, 1988, KIDNEY INT, V33, P189

[1] KIDNEY AND ERYTHROPOIESIS [J]. AMERICAN JOURNAL OF MEDICINE, 1968, 44 (05) : 725 - +

[2] BALDWIN DS, 1986, CONTEMP ISS NEPHROL, V14, P81

[3] BOMMER J, 1987, Nephrology Dialysis Transplantation, V2, P238

[4] RENAL FUNCTION DURING CHRONIC ANEMIA IN MAN [J]. BLOOD, 1947, 2 (02) : 192 - 202

[5] BROD J, 1967, ISRAEL J MED SCI, V3, P53

[6] BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS [J]. BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6605): : 1017 - 1020

[7] CAZZOLA M, 1987, BLOOD, V69, P296

[8] CHAPLIN H, 1953, CLIN SCI, V12, P359

[9] HEMATOPOIETIC INHIBITORS IN CHRONIC-RENAL-FAILURE - LACK OF INVITRO SPECIFICITY [J]. KIDNEY INTERNATIONAL, 1986, 29 (03) : 641 - 648

[10] ESCHBACH JW, 1988, KIDNEY INT, V33, P189